1 1

CLIA Kit for Fibroblast Growth Factor 13 (FGF13)

Size

TRV-049923-01

$322.16
$322.16
Sale Sold out
Shipping calculated at checkout.

CLIA Kit for Fibroblast Growth Factor 13 (FGF13) is a premium-quality life science research product supplied by Torvigen for laboratory and scientific applications.

View full details

Product specifications

Alternative Name FHF2; Fibroblast Growth Factor Homologous Factor 2
Name Synonym Fibroblast Growth Factor 13
Uniprot Q92913
Field of Research Cytokine
Applications Chemiluminescent immunoassay for Antigen Detection.
Organism Species Homo sapiens (Human)
Format 48T, 96T, 96Tx5, 96Tx10, 96Tx100
Specificity This assay has high sensitivity and excellent specificity for detection of Fibroblast Growth Factor 13 (FGF13) . No significant cross-reactivity or interference between Fibroblast Growth Factor 13 (FGF13) and analogues was observed.
Sensitivity The minimum detectable dose of this kit is typically less than 2.42pg/mL
Detection Range 6.17-500pg/mL
Precision Intra-assay Precision (Precision within an assay) : 3 samples with low, middle and high level Fibroblast Growth Factor 13 (FGF13) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays) : 3 samples with low, middle and high level Fibroblast Growth Factor 13 (FGF13) were tested on 3 different plates, 8 replicates in each plate. CV (%) = SD/meanX100 Intra-Assay: CV Inter-Assay: CV Inter-Assay: CV
Stability The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay Principle The microplate provided in this kit has been pre-coated with a monoclonal antibody specific to Fibroblast Growth Factor 13 (FGF13) . A competitive inhibition reaction is launched between biotin labeled Fibroblast Growth Factor 13 (FGF13) and unlabeled Fibroblast Growth Factor 13 (FGF13) (Standards or samples) with the pre-coated antibody specific to Fibroblast Growth Factor 13 (FGF13) . After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of Fibroblast Growth Factor 13 (FGF13) in the sample. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is reverse proportional to the Fibroblast Growth Factor 13 (FGF13) level in the sample or standard.
Assay Protocol 1. Prepare all reagents, samples and standards;
2. Add 50µ L standard or sample to each well.
        And then add 50µ L prepared Detection Reagent A immediately.
        Shake and mix. Incubate 1 hour at 37° C;
3. Aspirate and wash 3 times;
4. Add 100µ L prepared Detection Reagent B. Incubate 30 minutes at 37° C;
5. Aspirate and wash 5 times;
6. Add 100µ L Substrate Solution. Incubate 10 minutes at 37° C;
7. Read RLU value immediately.
Assay Performance Time 2h
Method Competitive Inhibition
Sample Type Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids

Related Research Products